After months of uncertainty, the outlook for key EU sustainability laws is far clearer.

On November 13, 2025, the European Parliament adopted its negotiating position on the Corporate Sustainability Reporting Directive (“CSRD”) and the Corporate Sustainability Due Diligence Directive (“CSDDD”) Omnibus simplification. This follows the European Commission’s Omnibus proposal in February (see more here) and the Council of the EU’s negotiating mandate in June (see more here). “Trilogue” negotiations between the three institutions began on November 18, 2025, with the aim of finalizing the legislation by the end of 2025 (see four-column document here).

This post uses the Parliament’s position as the basis to set out some of the key points on the CSRD and CSDDD that have been the focus of debate. It also flags some key outstanding discrepancies between the Parliament and Council positions which will need to be ironed out in the Trilogue negotiations. So while the legislative journey is not yet over, the emerging alignment on these texts is finally coming into greater focus. As a result, companies are now starting to reinvigorate their efforts to prepare for compliance, given the significant areas of convergence between the Parliament and Council (flagged in brackets below) and confirmation that both institutions continue to support the extraterritorial application of the CSRD and CSDDD to certain non-EU parent companies.

CSDDD

  • Applicability Thresholds (Parliament and Council aligned):
    • For EU-incorporated companies: 5,000+ employees and over EUR 1.5 billion in net worldwide turnover (on a consolidated basis for EU ultimate parent companies of corporate groups).
    • For non-EU-incorporated companies: EUR 1.5 billion in net turnover generated in the EU (on a consolidated basis for non-EU ultimate parent companies of corporate groups).
  • Timing (Parliament and Council not aligned):
    • Application: The Parliament proposes to maintain the CSDDD application timeline set out in the Commission’s “Stop the Clock” proposal, i.e., obligations will apply to all in-scope companies starting July 26, 2028. The Council, in contrast, proposes postponing the CSDDD’s application by another year, to July 26, 2029.
    • Transposition: The Parliament maintains the Commission position on the Member State transposition deadline (July 26, 2027), whereas the Council would also push this by a year (July 26, 2028).
  • Level of Harmonization (Parliament and Council partially aligned): All three institutions propose a significantly broader harmonization of CSDDD obligations across the Member States. Parliament proposes the most extensive harmonization with mandatory alignment for all provisions from Articles 6 to 16. Parliament also proposes deleting the provision that would allow Member States to introduce more stringent or more specific due diligence obligations. This expanded harmonization would substantially reduce the risk of fragmented national requirements across the EU.
  • Changes to Due Diligence Obligations (Parliament and Council not aligned): The main focus of recent debates has been the required approach to identification and assessment of adverse impacts (under Article 8). Some of the key areas of divergence are as follows:
    • Broader Value Chain Scope and Risk-Based Approach to the Identification and Assessment of Adverse Impacts: The Parliament proposes requiring a company to cover the entire in-scope chain of activities (including both direct and indirect business partners) when identifying and assessing adverse human rights and environmental impacts. Rather than limiting the due diligence obligations to specific “tiers” of the supply chain, the Parliament position emphasizes a risk-based approach that takes into account relevant risk factors. This is in contrast to the Commission and Council positions which seek to introduce a two-tiered approach that limits impact assessment obligations to a company’s own operations, its subsidiaries, and direct business partners in the chain of activities (with additional triggers for when indirect business partners may be included).
    • Reframed Risk Identification and Assessment Steps: The Parliament’s position reframes and somewhat limits the risk identification and assessment requirements:
      • Step One: Companies must first carry out a “scoping” exercise (revising the Commission’s “mapping exercise”), relying solely on “already reasonably available information” to identify general areas where adverse impacts are most likely to occur and most severe. During this initial phase, companies are expressly not required to request information from their business partners.
      • Step Two: Based on the results of their scoping exercise, companies would only proceed to a “further assessment” (replacing and limiting the Council’s “in-depth assessment”) where, based on “relevant and verifiable information,” they have “grounds to believe” that adverse impacts may arise or have arisen, and only in the areas that were previously identified to be most likely to occur and most severe.
    • Value Chain Information Cap: For the purposes of further assessments in “Step Two” above, companies must only seek information from business partners where necessary, and never in the areas where no likely and severe risks were identified. To protect smaller companies from burdensome requests, in-scope companies can only request additional information from business partners with fewer than 5,000 employees (in contrast to the Council’s 1,000 employee cap) as a last resort, and only if that information cannot reasonably be obtained by other means. All information requests must be targeted, reasonable, and proportionate.
    • Other Substantive Obligations (Parliament and Council aligned in key areas): While the nature of the other substantive obligations (Articles 9–16) is broadly aligned between the Parliament and Council positions, some differences must still be resolved. For example, in Articles 10 and 11, the Parliament has proposed that it will always be voluntary for a company to suspend a relationship with a business partner as a way to prevent or end adverse impacts (the Commission proposed these “last resort” measures as mandatory). The Parliament also proposes to shorten Article 15’s regular due diligence assessment interval to four years, in contrast to the five-year interval proposed by the Commission and Council.
  • Climate Transition Plans (“CTPs”) (Parliament and Council not aligned): The Parliament’s proposal removes the mandatory CTP requirement entirely by deleting Article 22. This differs from the Council’s position, which maintains the obligation for companies to have a CTP, albeit with reduced obligations.
  • Civil Liability (Parliament and Council aligned): Both the Parliament and Council support the Commission’s proposal to remove the mandatory EU-wide civil liability regime. Civil liability for CSDDD breaches would still be subject to the rules and procedures of each Member State’s national court system.
  • Penalties (Parliament and Council aligned): Both the Parliament and Council require the Commission, together with Member States, to develop penalty-setting guidance for supervisory authorities. The Parliament clarifies that this guidance should spell out the “appropriate level” of penalties, a requirement not included in the Council’s text. Instead, the Council’s position includes a mandatory “cap” on penalties in the operative provision. However, in the Recitals the Parliament also agrees with the Council that the maximum limit for pecuniary penalties should be set at 5% of the net worldwide turnover.

CSRD

  • Applicability Thresholds (Parliament and Council not aligned):
    • For EU companies: The Parliament’s proposal increases the proposed employee threshold to 1,750+ employees (the Council sets the threshold at 1,000+ employees). The Parliament maintains the Council’s proposed turnover requirement of over EUR 450 million.
    • For non-EU ultimate parent companies: The Parliament’s proposal limits applicability to non-EU ultimate parent companies that have an EU-incorporated subsidiary or branch in the EU that generates more than EUR 450 million in net turnover. The Council maintains the prior structure of the threshold that requires (i) a large EU subsidiary or branch and (ii) the non-EU parent to generate more than EUR 450 million of turnover “in the EU.”
    • The Parliament proposes to exempt from direct reporting requirements “financial holding” companies that have the sole purpose of acquiring and managing shares in other companies, without directly or indirectly being involved in the management of those companies. The subsidiaries of those companies may have reporting requirements, if they meet the applicability requirements in their own right.
    • Separately, on November 13, 2025, a Delegated Regulation entered into force that provides reporting relief for companies that were required to publish CSRD sustainability statements on FY 2024 data (Wave 1 companies). Applying retroactively from January 1, 2025, the Delegated Regulation ensures that companies in the first wave of CSRD reporting will not be required to disclose additional information when reporting on FY 2025 and FY 2026 data beyond what was in their FY 2024 sustainability statements.
  • ESRS (“European Sustainability Reporting Standards”): The Parliament’s position broadly aligns with the Commission’s proposal and the Council’s position that reporting standards must be simplified and reduced. The Parliament also tasks the Commission with developing sector-specific guidelines to assist voluntary sector-specific reporting. The European Financial Reporting Advisory Group (“EFRAG”) has announced that the next draft of the simplified ESRS will be released on December 4, 2025. EFRAG’s initial proposal for revisions in the Amended ESRS confirm that the CSRD’s distinct double materiality assessment will be preserved (albeit streamlined), and both the Council and the Parliament ask that the Commission provides further clarity on the application of the double materiality principle when it adopts the Amended ESRS as a delegated act.
  • Value Chain Information Cap: The Parliament proposes that companies reporting under the CSRD are not allowed to request information from companies with an average of less than 1,750 employees and a net turnover of EUR 450 million, beyond what is required under the voluntary reporting standard for non-listed micro, small and medium enterprises (“VSME”). By comparison, the Council limited this cap to companies not exceeding an average of 1,000 employees. This cap will only apply to information requests for CSRD reporting purposes, and not to other commercial information exchanges.
  • Taxonomy Reporting: As in the current CSRD, only companies within the proposed scope of CSRD reporting (which varies among the three institutions) will be required to report under Article 8 of the Taxonomy Regulation. The Parliament and the Council agree to delete the Commission’s proposed option to report on partial Taxonomy alignment.

We expect to see growing clarity on these outstanding questions over the coming weeks. By early 2026, there will likely be a final CSRD/CSDDD Omnibus that amends the current CSRD and CSDDD rules, and which Member States must then transpose into national law applicable to companies.

* * *

If you have any questions concerning the material discussed in this post, please contact the members of our Sustainability/Environmental, Social, and Governance (ESG) practice.

Photo of Zoé Bertrand Zoé Bertrand

Zoé Bertrand is an associate in the Sustainability and Life Sciences Practice Groups, where her practice covers ESG, sustainability, environmental, food, and pharmaceutical regulation. She has experience in a wide range of regulatory and compliance issues with a focus on EU, Belgian, and…

Zoé Bertrand is an associate in the Sustainability and Life Sciences Practice Groups, where her practice covers ESG, sustainability, environmental, food, and pharmaceutical regulation. She has experience in a wide range of regulatory and compliance issues with a focus on EU, Belgian, and French regulatory advice.

She advises on compliance with EU ESG regulations, encompassing the CSRD, the CSDDD, and the EUDR, covering aspects as scope, timeline, implementation, and enforcement. As part of her practice, Zoé also covers environmental matters including the urban wastewater treatment directive, extended producer responsibility, chemicals regulations, and greenwashing.

Zoé also assists clients with the implementation of the Nagoya Protocol and the access and benefit sharing rules of a number of jurisdictions. Zoé closely follows international developments on biodiversity.

Photo of Hannah Edmonds-Camara Hannah Edmonds-Camara

Hannah is a founding member of the firm’s Business and Human Rights (BHR) practice and advises on a breadth of BHR and ESG issues. In particular, Hannah has deep experience advising on the development and implementation of global human rights and environmental due…

Hannah is a founding member of the firm’s Business and Human Rights (BHR) practice and advises on a breadth of BHR and ESG issues. In particular, Hannah has deep experience advising on the development and implementation of global human rights and environmental due diligence programmes, in response to the evolving, global regulatory landscape.

She advises on: compliance with ESG disclosure and due diligence requirements, including the EU’s CSRD and CSDDD; BHR-related investigations and remediation strategies; responding to complaints raised through non-judicial grievance mechanisms (including OECD National Contact Points); ESG due diligence in an M&A context; global risk assessments; workplace culture reviews; design of project and issue-specific human rights frameworks and stakeholder engagement strategies; and policy engagement on BHR legislative files.

Photo of Daniel Feldman Daniel Feldman

Dan Feldman co-chairs the firm’s ESG and Business & Human Rights practices.

Drawing on his prior positions in government service spanning multiple Administrations, former Ambassador Dan Feldman’s practice focuses on environmental, social, and governance (ESG) counseling, business and human rights (BHR), global public…

Dan Feldman co-chairs the firm’s ESG and Business & Human Rights practices.

Drawing on his prior positions in government service spanning multiple Administrations, former Ambassador Dan Feldman’s practice focuses on environmental, social, and governance (ESG) counseling, business and human rights (BHR), global public policy, as well as broader international regulatory compliance. He is a member of the firm’s Global Problem Solving initiative.

As Chief of Staff and Counselor to Secretary John Kerry when he was appointed the first Special Presidential Envoy for Climate (SPEC) by President Biden, Dan helped drive the U.S. government’s international climate agenda, coordinating high level interagency policy-making, engaging with corporate stakeholders, and contributing to key bilateral and multilateral climate discussions, including the 2021 Leaders’ Summit on Climate and the landmark UN Conference of Parties (COP26) in Glasgow.

Previously, Dan served as deputy and then U.S. Special Representative for Afghanistan and Pakistan at the U.S. Department of State in the Obama Administration, as Director of Multilateral and Humanitarian Affairs at the National Security Council in the Clinton Administration, and as Counsel and Communications Adviser to the U.S. Senate Homeland Security and Governmental Affairs Committee. He also has served as a senior foreign policy and national security advisor to a number of Democratic presidential and Congressional campaigns.

Dan has extensive experience counseling multinational corporations on mitigating risk and maximizing opportunities in the development and implementation of their ESG and sustainability strategies, with a particular background in advising on BHR matters. He was one of the first attorneys in the U.S. to develop a practice in corporate social responsibility, and has been cited by Chambers for his BHR expertise. He assists clients in strategizing about their engagements with a range of key stakeholders, including Members of Congress, executive branch officials, foreign government officials and Embassy representatives, multilateral institutions, trade and industry associations, non-governmental organizations, opinion leaders, and journalists.

Photo of Seán Finan Seán Finan

Seán Finan is an associate in the Life Sciences team. His practice covers environmental, food and beverage and pharmaceutical regulation.

Seán has specific experience in a number of key areas for EU and UK clients in the technology, food and beverage, pharmaceutical, cosmetic…

Seán Finan is an associate in the Life Sciences team. His practice covers environmental, food and beverage and pharmaceutical regulation.

Seán has specific experience in a number of key areas for EU and UK clients in the technology, food and beverage, pharmaceutical, cosmetic and consumer goods industries, including:

Environmental and ESG compliance issues, including CSRD, CSDDD and green taxonomy issues; green public procurement issues; extended producer responsibility obligations, etc.;
Advertising claims, particularly environmental claims and greenwashing;
General food regulation; novel food regulation; genetically modified and “precision bred” products; and
Chemicals legislation (REACH, CLP, biocides, etc.).

Seán has represented clients in judicial review actions involving novel foods against multiple national regulators.

Seán is qualified in both England & Wales, and the Republic of Ireland.

Seán is a co lead of the firm’s Disability and Mental Health affinity group.

Photo of Cándido García Molyneux Cándido García Molyneux

Cándido García Molyneux provides clients with regulatory, policy and strategic advice on EU environmental and product safety legislation. He helps clients influence EU legislation and guidance and comply with requirements in an efficient manner, representing them before the EU Courts and institutions.

Cándido…

Cándido García Molyneux provides clients with regulatory, policy and strategic advice on EU environmental and product safety legislation. He helps clients influence EU legislation and guidance and comply with requirements in an efficient manner, representing them before the EU Courts and institutions.

Cándido co-chairs the firm’s Environmental Practice Group.

Cándido has a deep knowledge of EU requirements on chemicals, circular economy and waste management, climate change, energy efficiency, renewable energies as well as their interrelationship with specific product categories and industries, such as electronics, cosmetics, healthcare products, and more general consumer products. He has worked on energy consumption and energy efficiency requirements of AI models under the EU AI Act.

In addition, Cándido has particular expertise on EU institutional and trade law, and the import of food products into the EU. Cándido also regularly advises clients on Spanish food and drug law.

Cándido is described by Chambers Europe as being “creative and frighteningly smart.” His clients note that “he has a very measured, considered, deliberative manner,” and that “he has superb analytical and writing skills.”

Photo of Elise Hartnett Elise Hartnett

Elise Hartnett advises clients on EU and U.S. regulatory and policy matters across environmental, social, and governance (ESG), business and human rights (BHR), international trade, and public policy.

Her practice includes providing clients with tailored advice on EU sustainability laws, global supply chain…

Elise Hartnett advises clients on EU and U.S. regulatory and policy matters across environmental, social, and governance (ESG), business and human rights (BHR), international trade, and public policy.

Her practice includes providing clients with tailored advice on EU sustainability laws, global supply chain due diligence, human rights and environmental policy development, evolving greenhouse gas and corporate climate action reporting requirements, and navigating compliance risks under EU and international legal obligations.

Elise also maintains an active pro bono practice focused on media freedom, human rights, and access to justice.

Photo of Max Jerman Max Jerman

Max Jerman is an associate in the Life Sciences Practice group. Max advises clients across a wide range of regulatory and compliance issues in the pharmaceutical, food, and cosmetics sectors, with a focus on EU and Italian regulatory advice. He is a native…

Max Jerman is an associate in the Life Sciences Practice group. Max advises clients across a wide range of regulatory and compliance issues in the pharmaceutical, food, and cosmetics sectors, with a focus on EU and Italian regulatory advice. He is a native Italian and Slovenian speaker.

Photo of Lasse Luecke Lasse Luecke

Lasse Luecke advises clients on EU regulatory and policy matters with a focus on environmental, technology, and product safety legislation. He has particular expertise in radio equipment legislation, including radiofrequency spectrum use and availability, data center regulation, and sustainability reporting frameworks, where he…

Lasse Luecke advises clients on EU regulatory and policy matters with a focus on environmental, technology, and product safety legislation. He has particular expertise in radio equipment legislation, including radiofrequency spectrum use and availability, data center regulation, and sustainability reporting frameworks, where he supports companies in meeting complex and rapidly evolving compliance obligations. Lasse also helps clients anticipate legislative developments, shape regulatory strategy, and engage constructively with EU institutions and policymakers.

Photo of Paul Mertenskötter Paul Mertenskötter

Paul Mertenskötter advises companies, investors, and governments on regulatory sustainability, international trade, and public policy matters.

Paul has particular experience advising multinational companies on EU sustainability laws, including the Corporate Sustainability Reporting Directive (CSRD), the Corporate Sustainability Due Diligence Directive (CSDDD), the Taxonomy…

Paul Mertenskötter advises companies, investors, and governments on regulatory sustainability, international trade, and public policy matters.

Paul has particular experience advising multinational companies on EU sustainability laws, including the Corporate Sustainability Reporting Directive (CSRD), the Corporate Sustainability Due Diligence Directive (CSDDD), the Taxonomy Regulation, the Forced Labor Regulation, and the Carbon Border Adjustment Mechanism (CBAM). His practice also spans a wide range of climate change issues, including carbon offsets, accounting rules, and related international sustainability reporting frameworks such as the International Sustainability Standards Board (ISSB). Paul further advises clients on their strategic engagement with the rules of the World Trade Organization (WTO), free trade agreements, the Paris Agreement, and general public international law.

Prior to joining the firm, Paul was a Visiting Scholar at the WTO in Geneva, clerked at the International Court of Justice in The Hague, and was a Fellow at the Institute for International Law and Justice at NYU Law School.

Photo of Mary Mikhaeel Mary Mikhaeel

Mary Mikhaeel advises clients on developing sophisticated human rights compliance programs, based on human rights-focused hard law and international best practices. She works with clients to develop cutting edge solutions to forced labor supply chain risks, and also advises clients on a wide…

Mary Mikhaeel advises clients on developing sophisticated human rights compliance programs, based on human rights-focused hard law and international best practices. She works with clients to develop cutting edge solutions to forced labor supply chain risks, and also advises clients on a wide range of Customs matters.

As a member of Covington’s Business and Human Rights Practice Group, Mary supports companies in furthering their commitment to respecting human rights, as articulated in the UN Guiding Principles on Business and Human Rights (UNGPs). She has experience in assisting companies with building compliance programs, conducting human rights risk assessments and investigations, and developing human rights due diligence procedures.

Mary has extensive experience counseling clients across a wide range of industries on how to mitigate forced labor risks in the context of U.S. anti-forced labor laws, including the Uyghur Forced Labor Prevention Act (UFLPA) and Withhold Release Orders (WROs).

Mary is also a member of Covington’s customs practice and advises clients on a wide range of issues related to customs compliance and tariff mitigation strategies. She has experience advising clients on seeking ruling requests with Customs, assisting clients in submitting prior disclosures, and conducting internal compliance reviews.

Prior to law school, Mary was part of a research team that developed the Corporations and Human Rights Database, the first database created to monitor public allegations of business’ possible human rights violations. She also worked at the University of Minnesota’s Human Rights program on a variety of business and human rights matters, including issues related to a forced displacement case before the Inter-American Commission on Human Rights, and interned for a human rights non-government organization that holds consultative status with the United Nations.

Photo of Tom Plotkin Tom Plotkin

Tom Plotkin advises companies on a broad range of ESG and sustainability issues with a focus on social responsibility, including business and human rights, equity and civil rights, and external engagement and brand reputation.

As a member of Covington’s Business and Human Rights…

Tom Plotkin advises companies on a broad range of ESG and sustainability issues with a focus on social responsibility, including business and human rights, equity and civil rights, and external engagement and brand reputation.

As a member of Covington’s Business and Human Rights practice, Tom advises clients on all aspects of the corporate responsibility to respect human rights, including issues related to supply chain due diligence and responsible sourcing, downstream product use and human rights impacts, and strategies for integrating human rights oversight into broader compliance programs.

Tom is also a member of Covington’s Institutional Culture and Social Responsibility practice, where he assists companies in evaluating and managing the legal, business, and reputational risks associated with social impacts of business practices. Tom’s work in this area focuses on civil rights and diversity, equity, and inclusion.

As a member of Covington’s Sustainability practice, Tom draws on his social responsibility portfolio to assist companies in bridging internal practices and external engagement strategies. Tom assists with public ESG reporting, responding to shareholder ESG proposals, and external stakeholder engagement.

Tom is also a member of Covington’s Employment practice, where he advises on a range of domestic and international employment law issues.

Photo of Emma Sawatzky Emma Sawatzky

Emma Sawatzky advises clients on a range of human rights and sustainability issues and supports them in evaluating and addressing potential legal, operational, and reputational risks across geographies and sectors.

As a member of Covington’s Business and Human Rights and Sustainability Practice Groups…

Emma Sawatzky advises clients on a range of human rights and sustainability issues and supports them in evaluating and addressing potential legal, operational, and reputational risks across geographies and sectors.

As a member of Covington’s Business and Human Rights and Sustainability Practice Groups, Emma advises clients on the rapidly evolving legal and enforcement landscape. Emma has experience with preparing clients for modern slavery and sustainability reporting; conducting gap assessments and developing action plans for sophisticated compliance programs; formulating human rights policies; conducting BHR-related investigations and implementing remediation strategies; advising on human rights-related OECD proceedings; developing responsible sourcing frameworks (including risk assessments, traceability exercises, and supplier engagement strategies); and advising on the potential human rights impacts of downstream product and service use. Emma also assists clients with white collar investigations.

Photo of Pimara Soongswang Pimara Soongswang

Pimmy Soongswang is an associate in the Business and Human Rights (BHR) and Sustainability practice groups. She advises clients on their human rights obligations under international standards and supports them in navigating the evolving legal frameworks surrounding responsible business conduct.

Pimmy works across…

Pimmy Soongswang is an associate in the Business and Human Rights (BHR) and Sustainability practice groups. She advises clients on their human rights obligations under international standards and supports them in navigating the evolving legal frameworks surrounding responsible business conduct.

Pimmy works across a range of BHR-related matters, including global supply chain due diligence, modern slavery reporting, forced labour-related import bans, human rights policy development, and OECD proceedings involving human rights issues. Her practice also includes assessing downstream human rights risks associated with AI and other digital products within the context of developing human rights due diligence frameworks.

Pimmy is engaged in pro bono work focused on the rights of women and underrepresented communities. In addition to her client work, she contributes to the firm’s diversity and inclusion efforts

Photo of Bart Van Vooren Bart Van Vooren

Bart Van Vooren, partner leads a dynamic practice at the intersection of EU regulatory law, global health, and biodiversity law. In these fields, he advises innovative pharmaceutical, food, cosmetic and technology companies on complex EU and global regulatory, compliance and policy assignments.

Bart…

Bart Van Vooren, partner leads a dynamic practice at the intersection of EU regulatory law, global health, and biodiversity law. In these fields, he advises innovative pharmaceutical, food, cosmetic and technology companies on complex EU and global regulatory, compliance and policy assignments.

Bart holds a Ph.D. in EU and International Law and was a professor of EU law until 2013. During that time, he wrote the first-ever handbook with Cambridge University Press on “EU External Relations Law” (2014). He then transitioned to private practice, and frequently acted for the Belgian government before the EU Court of Justice (e.g. C-16/16P Belgium vs Commission). Bart joined Covington in 2016, leading some of our most consequential EU litigation proceedings (e.g. C-311/18 “Schrems II”) over the years.  Having handled nearly 50 cases before the EU Court, he’s uniquely qualified to support our corporate clients in our most high-stakes disputes. Recent examples include T-189/21 Aloe Vera of Europe v Commission (which we won, so the Commission decided to appeal); as well as T-201/21 Covington & Burling and Van Vooren v Commission (which we also won, and hence is also on appeal).

As a pioneer in biodiversity law, over the past 15 years Bart has built a unique, global practice on Access and Benefit-Sharing (ABS) laws under the Convention on Biological Diversity, the Nagoya Protocol, the Plant Treaty, the High Seas Treaty and the WHO Pandemic Agreement. ABS compliance is critical when sourcing biological materials for life sciences R&D and I work with many of the world’s innovative life sciences companies on the whole range of e.g. transactional, contractual, compliance, IP, (EU) regulatory and litigation work relating to ABS. As biodiversity has increasingly become identified as a major commercial and financial risk to companies, so has the practice expanded to e.g. biodiversity credit markets, biodiversity insurance, biodiversity claims and advertising, and so on. Since April 2025, Bart has been appointed as the industry representative to the Steering Committee of the UN Biodiversity Fund that seeks funding from the private sector for biodiversity conservation and restoration.

Bart also pioneered our global health practice. He has advised pharmaceutical clients on seasonal and pandemic influenza since 2016. Since then, this practice area expanded to cover all matters relating to infectious diseases, and as of 2020, emergency preparedness and response (eg. WHO prequalification, International Coordination Group negotiations, Emergency Use Listing, International Health Regulations Rev 2024). He has been the pharmaceutical industry’s lead lawyer advising on the WHO Pandemic Treaty negotiations, adopted on 14 May 2025. Currently, he continues to advise on the work of the Intergovernmental Working Group (“IGWG”) teasing out the technical details of the “Pathogen Access and Benefit-Sharing System” intended to create legally binding obligations on companies to commit vaccines, therapeutics and diagnostics in case of a new global health emergency.

In Chambers rankings, clients have kindly described Bart as “very knowledgeable, action-focused and service-focused lawyer”, adding that he “really tries to find a way of working through challenges”, am “customer-oriented” and provide “sound advice and reasonable options for our business with pros and cons.”

Finally, Bart has an active pro bono practice assisting NGOs defending the human rights of persons with a disability through strategic litigation before the EU Court.